Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.2005
-0.0100 (-4.75%)
At close: Apr 2, 2026, 4:00 PM EDT
0.2000
-0.0005 (-0.25%)
After-hours: Apr 2, 2026, 7:16 PM EDT
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $5.85 million as of April 2, 2026. Its market cap has decreased by -59.59% in one year.
Market Cap
5.85M
Enterprise Value
4.45M
1-Year Change
-59.59%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.28M to $5.85M, a decrease of -97.04%. That is a compound annual growth rate of -50.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 5.85M | -37.94% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.17% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NuCana | 6.41M |
| MetaVia | 6.36M |
| XTL Biopharmaceuticals | 6.29M |
| Xenetic Biosciences | 6.28M |
| Immuron | 6.27M |
| Artelo Biosciences | 6.19M |
| Cardio Diagnostics Holdings | 6.04M |
| Purple Biotech | 5.89M |